Though the S 500 dipped earlier this month, it's important to keep in mind that we're still in a very positive market environment. The bull market is going strong, with the benchmark rising 17% so far this year. And since bull phases generally last longer than bear ones, it's possible that the good times will keep on rolling.

How can you benefit? By scooping up a few players that haven't yet picked up momentum but have the potential to do so. Two great examples are biotech Moderna (NASDAQ: MRNA) and pharma giant (NYSE: PFE). They both soared early in the pandemic thanks to their top-selling vaccines, then suffered as that market lost steam. But there's more to these companies than just one product. Motley Fool contributors Adria Cimino and Keith Speights discuss these two high-potential stocks, both down more than 50% from their peaks, and why they're worth buying right now.

Image source: Getty Images.

Continue reading

Source Fool.com